Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Frontiers in Oncology
|
November 8, 2023
Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)
David Russo, Stéphane Dalle, Olivier Dereure, et al.
Journal of the American Academy of Dermatology
|
December 21, 2022
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort
Perrine Rousset, Stéphane Dalle, Laurent Mortier, et al.
Acta Dermato-Venereologica
|
March 19, 2015
Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma
Thomas Jouary, Emeline Kubica, Stéphane Dalle, et al.
Cancer
|
December 8, 2024
Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study
Iona Campo Le Brun, Séphane Dalle, Laurent Mortier, et al.
Journal of Hypertension
|
September 1, 2007
Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study
Joël Constans, Christine Germain, Philippe Gosse, et al.
Annals of the Rheumatic Diseases
|
July 5, 2022
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control study
Léo Plaçais, Stéphane Dalle, Olivier Dereure, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 12, 2024
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network
Robin Zagala, Stephane Dalle, Marie Beylot-Barry, et al.
JAMA Dermatology
|
May 2, 2019
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival
Anaïs Vallet, Bastien Oriano, Laurent Mortier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2013
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial
Florent Cachin, Elisabeth Miot-Noirault, Brigitte Gillet, et al.
Eclinicalmedicine
|
December 24, 2024
When to stop immunotherapy for advanced melanoma: the emulated target trials
Mathilde Amiot, Laurent Mortier, Stéphane Dalle, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Frontiers in Oncology
|
November 8, 2023
Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)
David Russo, Stéphane Dalle, Olivier Dereure, et al.
Journal of the American Academy of Dermatology
|
December 21, 2022
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort
Perrine Rousset, Stéphane Dalle, Laurent Mortier, et al.
Acta Dermato-Venereologica
|
March 19, 2015
Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma
Thomas Jouary, Emeline Kubica, Stéphane Dalle, et al.
Cancer
|
December 8, 2024
Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study
Iona Campo Le Brun, Séphane Dalle, Laurent Mortier, et al.
Journal of Hypertension
|
September 1, 2007
Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study
Joël Constans, Christine Germain, Philippe Gosse, et al.
Annals of the Rheumatic Diseases
|
July 5, 2022
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control study
Léo Plaçais, Stéphane Dalle, Olivier Dereure, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 12, 2024
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network
Robin Zagala, Stephane Dalle, Marie Beylot-Barry, et al.
JAMA Dermatology
|
May 2, 2019
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival
Anaïs Vallet, Bastien Oriano, Laurent Mortier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2013
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial
Florent Cachin, Elisabeth Miot-Noirault, Brigitte Gillet, et al.
Eclinicalmedicine
|
December 24, 2024
When to stop immunotherapy for advanced melanoma: the emulated target trials
Mathilde Amiot, Laurent Mortier, Stéphane Dalle, et al.
Page
of 4